8 results

• Corticosteroid Knee Injections May Actually Worsen Progression of Osteoarthritis: Study

  November 30, 2022

  Martha Garcia

  A new study warns that corticosteroid injections to treat osteoarthritis of the knee can result in disease progression while providing little pain relief.

• Risk for Hip, Knee Replacements May Be Predicted By Genetics: Study

  May 10, 2022

  Russell Maas

  A new study finds there may be a genetic component which increases the risk of needing knee or hip replacement revision surgery.

• Hip and Knee Replacement May Lower Fall Risks For Elderly Patients: Study

  November 2, 2020

  Irvin Jackson

  A new study finds that undergoing total hip or knee replacement surgery may help reduce the risk of elderly falls.

• Fish Oil, Vitamin D Supplements Fail To Alleviate Chronic Knee Pain: Study

  June 30, 2020

  Martha Garcia

  A new study finds that fish oil and vitamin D supplements do little to help stave off the effects of osteoarthritis.

• Physical Therapy Better At Preventing Osteoarthritis Knee Pain Than Steroid Injections: Study

  April 17, 2020

  Martha Garcia

  A new study indicates patients with knee arthritis fare better with physical therapy than from receiving steroid injections for recovery and pain management.

• Corticosteroid Injections More Dangerous To Patients Than Previously Thought: Study

  October 18, 2019

  Martha Garcia

  A new study warns that the side effects and complications from using corticosteroids for temporary osteoarthritis pain relief may do more harm than good.

• Limbrel Recall Issued Over Liver Injury Risks

  January 31, 2018

  Irvin Jackson

  A Limbrel recall comes about a month after the FDA began pressuring Primus Pharmaceuticals to remove the osteoarthritis medical food products from the market following reports of liver injury and hypersensitivity.

• Limbrel Side Effects Linked To Liver Injury Risks, FDA Warns

  December 6, 2017

  Irvin Jackson

  The FDA is urging consumers not to use Limbrel, capsules marketed as medical food for the treatment of osteoarthritis, due to liver and hypersensitivity risks. It has also called for a Limbrel recall, but the manufacturer has so far refused to comply.